Leucine supplementation does not attenuate the decline in daily muscle protein synthesis rates or preserve leg muscle mass during leg immobilization in young or older adults: a double-blind randomized trial
Leucine supplementation does not attenuate the decline in daily MPS rates or muscle mass during short-term limb immobilization in young or older adults. Clinical Trial Register No. (Netherlands Trial Register): NL-OMON45771.
Authors
- Cas Fuchs
- L L. van Loon
- Stefan H. M. Gorissen (ORCID: https://orcid.org/0000-0003-3737-9053)
- Joey S.J. Smeets (ORCID: https://orcid.org/0000-0003-2877-0114)
- Joan M. Senden (ORCID: https://orcid.org/0000-0001-5078-506X)
- Tyler A. Churchward-Venne
- Will K.W.H. Wodzig
- Annemie P. Gijsen
- Gabriel Nasri Marzuca-Nassr
- Philippe J.M. Pinckaers
- Joy P.B. Goessens
Institutions
- McGill University Health Centre (CA)
- Maastricht University (NL)
- McGill University (CA)
Publication Details
- Journal
- American Journal of Clinical Nutrition
- Published
- 2026-01-23
- DOI
- https://doi.org/10.1016/j.ajcnut.2026.101205
- Primary Topic
- Muscle metabolism and nutrition
- Type
- article
- Field-Weighted Citation Impact
- 0.00